ESH Translational Research Conferences propose programmes of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international audience of biologists and clinicians, including those still in-training. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Chairs: Jean-Jacques Kiladjian, Ross L. Levine, Ann Mullally, Jyoti Nangalia

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

 

This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.

 

Posters and Brief Oral Communications:

Registered participants are invited to submit their abstracts. Selected abstracts are eligible for an oral or a poster presentation.

Call for abstracts: Deadline: January 26, 2026

 

Scientific Topics:

• Somatic evolution and MPN

• New approaches for targeting MPN

• New causes and classification

• Recent developments in blast phase MPN

• Novel functional insights downstream of JAK/CALR/MPL

• MPN management

• Disease mechanisms in MPN

• Aberrant cell populations in MPN

• New frontiers in MPN, where is the field going?

 

The programme will include:

– Plenary Sessions

– Keynote Lectures

– Panel Discussions

– Simultaneous Meet the Expert Sessions

– Mentored Poster Walks

– Brief Oral Communications

– Ample time for in-depth discussion

 

The meeting will be of interest to:

• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)

• Junior scientists and clinicians (MD, PhD)

• PhD candidates and clinical residents still in-training

 

Learning Objectives:

Upon completion of this CME activity, participants should:

1. To understand the newest discoveries on the molecular pathogenesis of MPN

2. To appreciate recent changes in treatment recommendations for MPN patients including the evolving landscape of

approved therapies

3. To gain insight into ongoing clinical trials investigating novel agents for MPN treatment

Register here

Direct email queries to: [email protected]

 

External Events

Nov 26
24
25
26
Jan 27
18
19
28
Feb 27
1
24
25
26
November 24th 2026
Current Thinking in Haematological Malignancies...
The programme for this meeting has been designed to combine high calibre lectures and interactive discussions to prov...
Details
November 25th 2026
RCPath & SHOT Advances in Transfusion Symposium...
This popular biennial symposium brings together expert speakers in transfusion medicine and science. It is suitable f...
Details
November 26th 2026
Glasgow Surgical Forum 2026
Advances in Surgical Oncology: Evidence, Practice and Outcomes'. An essential update for the general and specialist s...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch (1)
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
January 18th 2027
Multiple Myeloma Preceptorship 2027
Join us for our face-to-face preceptorship programme. You will receive the latest updates regarding Multiple Myeloma...
Details
January 19th 2027
Post ASH Significant Highlights (6)
An annual January event , where highlights will be presented from the ASH meeting. The aim of this 2 day event is to...
Details
January 28th 2027
Innovations in Transplant and Cellular Therapy
The programme for the Innovations in Transplant and Cellular Therapy Day will focus on novel therapies, transplant co...
Details
February 1st 2027
CLL and Lymphomas in Practice Preceptorship 2027
Join us to explore the latest approaches to managing chronic lymphocytic leukaemia (CLL), follicular lymphoma, margin...
Details
February 24th 2027
UCLH: Challenges in MPN - Medical
Join us for a clinically focused and highly interactive study day dedicated to the management of complex MPN (myelopr...
Details
February 25th 2027
UCLH: Challenges in MPN - Nursing
This study day has been designed specifically for Clinical Nurse Specialists working with patients living with myelop...
Details
February 26th 2027
OB Shock: Hemorrhage, Hemodynamics & Hemostasis...
This multidisciplinary workshop advances clinical decision-making in complex obstetric hemorrhage through applied coa...
Details